{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:14:58Z","timestamp":1787026498358,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["4000096"],"award-info":[{"award-number":["4000096"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Combined immune deficiencies (CIDs) with associated or syndromic features are a highly heterogeneous subgroup of inherited immune disorders. These patients represent specific clinical complications with an increased risk of autoimmune conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We analyzed data of monogenic patients with syndromic CIDs adopted from the Iranian inborn errors of immunity registry up to January 2022. A comprehensive comparison in terms of demographic, clinical, and immunological features was performed between patients with and without autoimmunity and also among four mutation groups with the most registered cases including\n                      <jats:italic>ATM<\/jats:italic>\n                      ,\n                      <jats:italic>STAT3 (AD-LOF)<\/jats:italic>\n                      ,\n                      <jats:italic>DNMT3B\/ZBTB24<\/jats:italic>\n                      , and\n                      <jats:italic>WAS<\/jats:italic>\n                      mutations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 137 patients with monogenic syndromic CIDs were included. Most commonly mutated genes were the\n                      <jats:italic>ATM<\/jats:italic>\n                      [80 (58.4%)] and\n                      <jats:italic>STAT3 (AD-LOF)<\/jats:italic>\n                      [19 (13.9%)], followed by\n                      <jats:italic>DNMT3B<\/jats:italic>\n                      [11 (8%)], and\n                      <jats:italic>WAS<\/jats:italic>\n                      [11 (8%)]. More than 18% of all patients with syndromic CIDs, including most\n                      <jats:italic>DNMT3B\/ZBTB24<\/jats:italic>\n                      mutations patients, were clinically diagnosed with antibody deficiencies before genetic evaluation. Patients with\n                      <jats:italic>ATM<\/jats:italic>\n                      and\n                      <jats:italic>WAS<\/jats:italic>\n                      mutations had the latest age of onset and the lowest age of diagnosis, respectively. Autoimmune disorders were diagnosed in 24 patients at a median age of 3.5 (2.6-6.0) years, 70.6% of which were diagnosed prior to the diagnosis of immunodeficiency. Lymphoproliferation, particularly hepatosplenomegaly, was significantly higher in patients with autoimmunity (\n                      <jats:italic>p=0.004<\/jats:italic>\n                      ). Syndromic CID patients with autoimmunity had significantly lower IgG levels. Hematologic autoimmunity mainly immune thrombocytopenic purpura was the most frequent autoimmunity among major groups of\n                      <jats:italic>ATM<\/jats:italic>\n                      ,\n                      <jats:italic>STAT3 (AD-LOF)<\/jats:italic>\n                      ,\n                      <jats:italic>DNMT3B\/ZBTB24<\/jats:italic>\n                      , and\n                      <jats:italic>WAS<\/jats:italic>\n                      mutations, however\n                      <jats:italic>ATM-<\/jats:italic>\n                      mutated patients present more diversified involved organs including rheumatologic, gastrointestinal and dermatologic autoimmunity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>About 18% of patients with monogenic syndromic CIDs developed autoimmunity, mainly in the form of hematological immune diseases. Autoimmunity could be an early-onset involvement with a potential diagnostic impact on suspicious cases of syndromic CIDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2022.1023127","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T02:20:27Z","timestamp":1670206827000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Autoimmunity in monogenic combined immune deficiencies with associated or syndromic features"],"prefix":"10.3389","volume":"13","author":[{"given":"Niusha","family":"Sharifinejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Chavoshzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Alireza","family":"Mahdaviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz Seifi","family":"Alan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Tavakol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homa","family":"Sadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sareh Sadat","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Shirkani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Vosughi Motlagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molood","family":"Safarirad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Aghamahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Delavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Jamee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farimah","family":"Fayyaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Samimisedeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahman","family":"Matani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzie","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Abolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/B978-0-12-821028-4.00010-5","article-title":"Chapter 2 - immunodeficiencies affecting cellular and humoral immunity","volume-title":"Inborn errors of immunity","author":"Chavoshzadeh","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"B4","article-title":"Heterogeneity in combined immunodeficiencies with associated or syndromic features (Review)","volume":"21","author":"Caba","year":"2021","journal-title":"Exp Ther Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/1744666x.2016.1177458","article-title":"Autoimmunity in primary T-cell immunodeficiencies","volume":"12","author":"Azizi","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"B6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/B978-0-323-85415-3.00004-0","article-title":"Chapter 5 - autoimmunity in combined immunodeficiency","volume-title":"Translational autoimmunity","author":"Gennery","year":"2022"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e328353fa13","article-title":"Lymphoma complicating primary immunodeficiency syndromes","volume":"19","author":"Leechawengwongs","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","article-title":"Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies","volume":"140","author":"Fischer","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrrheum.2017.198","article-title":"Autoimmunity and primary immunodeficiency: two sides of the same coin","volume":"14","author":"Schmidt","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The European society for immunodeficiencies (ESID) registry working definitions for the Clinical\u00a0Diagnosis of inborn errors of immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J Allergy Clin Immunol: In Practice"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.06.049","article-title":"Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency","volume":"141","author":"Abolhassani","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-018-0012-x","article-title":"Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency","volume":"21","author":"Abolhassani","year":"2019","journal-title":"Genet Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000929","article-title":"Current genetic landscape in common variable immune deficiency","volume":"135","author":"Abolhassani","year":"2020","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"crossref","first-page":"bbac176","DOI":"10.1093\/bib\/bbac176","article-title":"VIPPID: a gene-specific single nucleotide variant pathogenicity prediction tool for primary immunodeficiency diseases","volume":"23","author":"Fang","year":"2022","journal-title":"Brief Bioinform"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2006.00409.x","article-title":"Consanguinity in primary immunodeficiency disorders; the report from Iranian primary immunodeficiency registry","volume":"56","author":"Rezaei","year":"2006","journal-title":"Am J Reprod Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1601-0825.2008.01463.x","article-title":"Hyper IgE (Job\u2019s) syndrome: a primary immune deficiency with oral manifestations","volume":"15","author":"Freeman","year":"2009","journal-title":"Oral Diseases"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13043","article-title":"The first cohort of Iranian patients with hyper immunoglobulin e syndrome: A long-term follow-up and genetic analysis","volume":"30","author":"Tavassoli","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-818731-9.00224-X","article-title":"Combined immunodeficiencies with syndromic features","volume-title":"Encyclopedia of infection and immunity","author":"Ochs","year":"2022"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2147\/tacg.S213920","article-title":"Autoimmunity in wiskott-Aldrich syndrome: Updated perspectives","volume":"14","author":"Sudhakar","year":"2021","journal-title":"Appl Clin Genet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-016-0240-2","article-title":"Genetic, cellular and clinical features of ICF syndrome: a French national survey","volume":"36","author":"Sterlin","year":"2016","journal-title":"J Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000400","article-title":"Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance","volume":"3","author":"Hollenhorst","year":"2019","journal-title":"Blood Adv"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13387","article-title":"Parents of ataxia-telangiectasia patients display a distinct cellular immune phenotype mimicking ATM-mutated patients","volume":"32","author":"Ogulur","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J Rare Diseases"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.202374","article-title":"Multisystem autoimmune disease caused by increased STAT3 phosphorylation and dysregulated gene expression","volume":"104","author":"Todaro","year":"2019","journal-title":"Haematologica"},{"key":"B26","doi-asserted-by":"publisher","first-page":"11892","DOI":"10.3390\/ijms222111892","article-title":"Contribution of dysregulated DNA methylation to autoimmunity","volume":"22","author":"Funes","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00185","article-title":"Early-onset autoimmune disease as a manifestation of primary immunodeficiency","volume":"6","author":"Carneiro-Sampaio","year":"2015","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1126\/stke.3802007tw113","article-title":"STAT3 regulates the generation of Th17 cells","volume":"2007","author":"Foley John","year":"2007","journal-title":"Science\u2019s STKE"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2016.71","article-title":"Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity","volume":"5","author":"Okada","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.01.030","article-title":"Increased risk of cutaneous and systemic infections in atopic dermatitis-a cohort study","volume":"137","author":"Langan","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2020.1723104","article-title":"Effect of class switch recombination defect on the phenotype of ataxia-telangiectasia patients","volume":"50","author":"Amirifar","year":"2021","journal-title":"Immunol Invest"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.779502","article-title":"Atypical ataxia presentation in variant ataxia telangiectasia: Iranian case-series and review of the literature","volume":"12","author":"Moeini Shad","year":"2022","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-015-0197-6","article-title":"Primary immunodeficiency diseases in Saudi Arabia: a tertiary care hospital experience over a period of three years (2010\u20132013)","volume":"35","author":"Al-Saud","year":"2015","journal-title":"J Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13223-016-0166-5","article-title":"Gene mutations responsible for primary immunodeficiency disorders: A report from the first primary immunodeficiency biobank in Iran","volume":"12","author":"Sheikhbahaei","year":"2016","journal-title":"Allergy Asthma Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1023127\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T02:20:31Z","timestamp":1670206831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1023127\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2022.1023127"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1023127","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"article-number":"1023127"}}